Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study.
Korotych O, Achar J, Gurbanova E, Hovhannesyan A, Lomtadze N, Ciobanu A, Skrahina A, Dravniece G, Kuksa L, Rich M, Khachatryan N, Germanovych M, Kadyrov A, Terleieva I, Akhundova I, Adenov M, Durdyeva M, Kiria N, Parpieva N, Yatskevich N, Jumayev R, Nurov R, Diktanas S, Vilc V, Migliori GB, Yedilbayev A. Korotych O, et al. Among authors: hovhannesyan a. Lancet Infect Dis. 2024 Oct;24(10):1151-1161. doi: 10.1016/S1473-3099(24)00228-7. Epub 2024 Jun 13. Lancet Infect Dis. 2024. PMID: 38880112 Free PMC article.
Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019-2020.
Avaliani T, Sereda Y, Davtyan H, Tukvadze N, Togonidze T, Kiria N, Denisiuk O, Gozalov O, Ahmedov S, Hovhannesyan A. Avaliani T, et al. Among authors: hovhannesyan a. Monaldi Arch Chest Dis. 2021 Jan 14;91(1):10.4081/monaldi.2021.1679. doi: 10.4081/monaldi.2021.1679. Monaldi Arch Chest Dis. 2021. PMID: 33470088 Free PMC article.
Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018.
Buziashvili M, Davtyan H, Sereda Y, Denisiuk O, Gozalov O, Lomtadze N, Hovhannesyan A. Buziashvili M, et al. Among authors: hovhannesyan a. Monaldi Arch Chest Dis. 2021 Jan 14;91(1):10.4081/monaldi.2021.1649. doi: 10.4081/monaldi.2021.1649. Monaldi Arch Chest Dis. 2021. PMID: 33470083 Free PMC article.
Incidence Rate and Risk Factors for Tuberculosis among People Living with HIV: A 2015-2017 Cohort from Tashkent, Uzbekistan.
Sadirova D, Grigoryan R, Parpieva N, Barotova V, Trubnikov A, Kalandarova L, Gadoev J, Mukhtarov D, Buziashvili M, Tukvadze N, Hovhannesyan A, Dadu A. Sadirova D, et al. Among authors: hovhannesyan a. Int J Environ Res Public Health. 2021 May 27;18(11):5746. doi: 10.3390/ijerph18115746. Int J Environ Res Public Health. 2021. PMID: 34071899 Free PMC article.
Diagnostic Procedures, Diagnoses, and Treatment Outcomes of Patients with Presumptive Tuberculosis Pleural Effusion in Uzbekistan.
Abdugapparov F, Grigoryan R, Parpieva N, Massavirov S, Riskiyev A, Gadoev J, Buziashvili M, Tukvadze N, Hovhannesyan A, Dadu A. Abdugapparov F, et al. Among authors: hovhannesyan a. Int J Environ Res Public Health. 2021 May 27;18(11):5769. doi: 10.3390/ijerph18115769. Int J Environ Res Public Health. 2021. PMID: 34072161 Free PMC article.
TB prevention activities in the WHO European Region.
Matteelli A, Mkrtchyan Z, Masini T, Hovhannesyan A, Kuchukhidze G, Ahmedov S, Kerndt P, Rossi L, Yedilbayev A, Falzon D, Dadu A. Matteelli A, et al. Among authors: hovhannesyan a. IJTLD Open. 2024 Aug 1;1(8):349-354. doi: 10.5588/ijtldopen.24.0350. eCollection 2024 Aug. IJTLD Open. 2024. PMID: 39131590 Free PMC article.
18 results